Monitor future R&D productivity and clinical development timelines to assess the impact of this leadership change. The lack of compensation adjustment suggests this is a structural promotion rather than a new hire with potential integration risks.
Price Chart
Executive Summary
Jade Biosciences appointed Andrew King, previously Chief Scientific Officer and Head of R&D, as President of Research & Development effective April 18, 2026. No compensation changes were made in connection with the appointment.
Key Facts
- Andrew King was appointed President, Research & Development effective April 18, 2026
- Dr. King was previously Chief Scientific Officer and Head of Research & Development
- No changes were made to Dr. King's compensation in connection with the appointment
- The appointment reflects a promotion within the existing R&D leadership structure
Financial Impact
No immediate financial impact as there were no changes to executive compensation
Risk Factors
- Potential disruption during leadership transition in R&D function
- No indication of expanded resources or budget for R&D despite leadership elevation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-168351 |
| Document: 0001193125-26-168351-index-headers.html | 0001193125-26-168351 |
| Document: 0001193125-26-168351-index.html | 0001193125-26-168351 |
| Document: 0001193125-26-168351.txt | 0001193125-26-168351 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 27d ago | 8-K | $14.05 $13.77 | ▼ −1.99% | ▼ −3.91% | $14.74 (+4.91%) |
Aug 10, 2026 11w ago | 8-K | $21.73 $23.45 | ▲ +7.92% | ▲ +7.96% | $14.74 (−32.17%) |
Aug 10, 2026 11w ago | Press Release | $21.73 $23.45 | ▲ +7.92% | ▲ +7.96% | $14.74 (−32.17%) |
Jun 5, 2026 20w ago | Press Release | $14.98 $16.10 | ▼ −7.48% | ▼ −5.37% | $14.74 (+1.60%) |
Jun 4, 2026 20w ago | 8-K | $16.94 $15.34 | ▲ +9.45% | ▲ +10.01% | $14.74 (+12.99%) |
Jun 4, 2026 20w ago | 424B5 | $16.94 $15.34 | ▲ +9.45% | ▲ +10.01% | $14.74 (+12.99%) |
Jun 3, 2026 20w ago | Press Release | $17.74 $16.08 | ▲ +9.36% | ▲ +6.80% | $14.74 (+16.91%) |
Jun 3, 2026 20w ago | 424B5 | $17.74 $16.08 | ▲ +9.36% | ▲ +6.80% | $14.74 (+16.91%) |
Jun 3, 2026 20w ago | Press Release | $17.74 $16.08 | ▲ +9.36% | ▲ +6.80% | $14.74 (+16.91%) |
Jun 1, 2026 21w ago | 8-K | $18.59 $16.94 | ▼ −8.88% | ▼ −6.13% | $14.74 (−20.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers